Overview Fundamentals API Earnings EOD API Sample Code Pricing

Natco Pharma Limited (NATCOPHARM NSE) stock market data APIs

INR1373.5 18.25(1.3%) as of November 26, 2024
Price chart is built with Anychart

NATCO Pharma Limited, a pharmaceutical company, engages in the developing, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally. It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; and APIs in various categories, such as oncology, central nervous system, pain management, and cardiovascular care. The company offers orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, it provides cardiology and diabetology products for the treatment of hypertension, stable angina, and CHF. Further, the company offers agro chemicals and biological pest management solutions for management of insects, diseases, and weeds across a range of crops. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.

Natco Pharma Limited Financial Data Overview

1355.25
1373.5
-
1378.9
1350.1
750.0815-1639
244 476 M
12.5674
179 M
45 638 M
37.81
0.0042
0.519
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'NATCOPHARM',
Type: 'Common Stock',
Name: 'Natco Pharma Limited',
Exchange: 'NSE',
CurrencyCode: 'INR',
CurrencyName: 'Indian Rupee',
CurrencySymbol: 'INR',
CountryName: 'India',
CountryISO: 'IN',
OpenFigi: NULL,
ISIN: 'INE987B01026',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'March',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - Specialty & Generic',
}

Natco Pharma Limited Fundamental Data is available in our Financial Data APIs

  • Net Revenue 45 638 M
  • EBITDA 23 737 M
  • Earnings Per Share 108.61
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Natco Pharma Limited Earnings via APIs

  • Latest Release 2024-11-12
  • EPS/Forecast 31.5

Get Natco Pharma Limited End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com